医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

NCKU, Duke University Researchers Successfully Implant a New Cardiac Assist Device on Calf

2013年10月29日 PM12:55
このエントリーをはてなブックマークに追加


 

TAINAN, Taiwan

The National Cheng Kung University Heart Science and Medical Devices Research Center (NCKU HSDMRC) and the Division of Cardiothoracic Surgery, Department of Surgery, Duke University, Durham, NC, USA, jointly carried out a cardiac assist device implantation on calf recently.

Roberto Manson and Mani Daneshmand from Cardiothoracic Surgery, Duke University Medical Center attended the workshop of Duke-NCKU collaboration on early interventional ventricular assist device hosted by NCKU, October 13-16, and participated in the para-aortic blood pump (PABP) implantation surgery on calf.

NCKU HSDMRC Director Pong-Jeu Lu, who is also a professor at the NCKU Department of Aeronautics and Astronautics, had led his research team to develop the PABP for over thirteen years.

He said, “PABP is a new type of left ventricular assist device which has completed major design, prototype manufacturing and testing after more than 10 years of effort.”

“This study could be extended to humans where clinical trials are to be conducted within the next two years, which will benefit more patients with heart failure in the future,” Manson noted.

“It is worthwhile mentioning that PABP is designed to be implanted in patients with heart failure prior to irreversible stage to hopefully restore heart function,” according to Lu.

However, the most important part would be the minimally invasive surgery, which allows rapid implantation into the aorta without affecting heart functions, thus shortening the recovery time after surgery.

Last year, Lu’s research team had signed a 3-year Agreement with the Division of Cadiothoracic Surgery, Department of Surgery at Duke University on the research development of cardiac assist device, efficacy and safety regarding surgical treatment on patients with heart failure and the pathway of cell recovery after long-term PABP support.

“NCKU’s PABP research outcome can be applied on patients with heart failure of non-refractory stage,” noted Daneshmand who was impressed by NCKU’s latest medical invention. He also added, “It can also be used to restore heart function of patients with late stage heart failure and prolong patient’s life with reasonable quality; hence it is a very advanced piece of medical innovation.”

Manson added, “It is an exciting result that the calf has strong heartbeat after surgery.” The research entering the phase of human trials within two years is foreseeable.

CONTACT

National Cheng Kung University
Sonia Chuang, +886-6-275-7575 ext.
50042
News Center
sonia20@mail.ncku.edu.tw

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Morinaga Milk Study Suggests Infant-Type Human-Residential Bifidobacteria May Benefit Infant Health by Improving Digestion of Peptides in Milk and Grains
  • CANbridge Pharmaceutical and WuXi Biologics Enter into Strategic Partnership for Rare Disease Therapeutics
  • 武田呈报3期ALTA-1L试验结果,显示在晚期ALK+非小细胞肺癌一线治疗中,ALUNBRIG® (brigatinib)的颅内有效性优于克唑替尼
  • Philip Morris International Launches Next Generation of IQOS, the World’s Leading Heated Tobacco Product
  • PotNetwork Holdings, Inc.第三季度业绩创纪录,营收超过610万美元